Identification of potent and selective PDE5 inhibitor discussed at Pharmaceutical Society meeting April 19, 2000
Sanofi-Synthelabo presents alpha-adrenoceptor ligands for incontinence, venous insufficiency, etc. April 19, 2000
Tolterodine emerges triumphant from long-term studies supporting the drug as "gold standard" April 18, 2000
Novel series of PDE5 inhibitors claimed by Bristol-Myers Squibb for erectile dysfunction Rx April 14, 2000
L-Arginine prevents chronic ciclosporin-induced renal dysfunction in heart transplant recipients April 12, 2000
RSS